IX. DRUGS USED IN AMYOTROPHIC LATERAL SCLEROSIS

Though not indicated for the treatment of Alzheimer disease, another NMDA-receptor antagonist is indicated for the management of ALS. Riluzole blocks glutamate, sodium channels, and calcium channels. It may improve the survival time and delay the need for ventilator support in patients suffering from ALS